18F-DOPA-PET and Advanced MRI Improve Treatment Response Assessment in <i>IDH1/2</i> -Mutant Gliomas Treated with IDH Inhibitors

20260 citationsJournal Article

Authors

Diego Prost · Centre National de la Recherche Scientifique

Lucia Nichelli · Centre National de la Recherche Scientifique

Laura Rozenblum · Centre National de la Recherche Scientifique

Alice Laurenge · Centre National de la Recherche Scientifique

Caroline Dehais · Centre National de la Recherche Scientifique

Bertrand Mathon · Centre National de la Recherche Scientifique

Abstract

These results highlight the potential of ¹⁸F-DOPA-PET and advanced MRI sequences as valuable complements to standard RANO 2.0 MRI evaluations for assessing treatment response in glioma patients undergoing IDHi therapy.

Topics & Keywords

Glioma Diagnosis and Treatment Brain Metastases and Treatment Protein Degradation and Inhibitors

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-25-0279

Field-Weighted Citation Impact: 0.00